Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma (Q45183209)
Jump to navigation
Jump to search
scientific article published in December 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma |
scientific article published in December 2004 |
Statements
1 reference
Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma (English)
1 reference
Fink W
1 reference
Zimpfer-Rechner C
1 reference
Thoelke A
1 reference
Figl R
1 reference
Kaatz M
1 reference
Ugurel S
1 reference
Schadendorf D
1 reference
1 December 2004
1 reference
1 reference
27
1 reference
6
1 reference
540-544
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference